What a polyclonal antibody sees in von Willebrand factor

Thrombosis Research

Volumn 121, Issue 4, 2008, Pages 519-526

  Tan, Fen Lai ^a   Ginsburg, David ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; EPITOPE; POLYCLONAL ANTIBODY; VON WILLEBRAND FACTOR;

AMINO ACID SEQUENCE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE;

ANIMALS; ANTIBODIES; ANTIBODIES, MONOCLONAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HUMANS; MICE; RABBITS; VON WILLEBRAND FACTOR;

EID: 38649118524     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2007.05.015     Document Type: Article

References (27)

1. Mendolicchio G.L., and Ruggeri Z.M. New perspectives on von Willebrand factor functions in hemostasis and thrombosis. Semin Hematol 42 (2005) 5-14
2. Sadler J.E. von Willebrand factor: two sides of a coin. J Thromb Haemost 3 (2005) 1702-1709
3. Montgomery R.R., and Gill J.C. Interactions between von Willebrand factor and Factor VIII: where did they first meet. J Pediatr Hematol Oncol 22 (2000) 269-275
4. Huizinga E.G., Tsuji S., Romijn R.A.P., Schiphorst M.E., de Groot P.G., Sixma J.J., et al. Structures of glycoprotein Ib alpha and its complex with von Willebrand factor A1 domain. Science 297 (2002) 1176-1179
5. Matsushita T., Meyer D., and Sadler J.E. Localization of von Willebrand factor-binding sites for platelet glycoprotein Ib and botrocetin by charged-to-alanine scanning mutagenesis. J Biol Chem 275 (2000) 11044-11049
6. Huizinga E.G., vanderPlas R.M., Kroon J., Sixma J.J., and Gros P. Crystal structure of the A3 domain of human von Willebrand factor: implications for collagen binding. Structure 5 (1997) 1147-1156
7. Sadler J.E. Biochemistry and genetics of von Willebrand factor. Ann Rev Biochem 67 (1998) 395-424
8. Levy G.G., Motto D.G., and Ginsburg D. Adamts13 turns 3. Blood 106 (2005) 11-17
9. Rowley M.J., O'connor K., and Wijeyewickrema L. Phage display for epitope determination: a paradigm for identifying receptor-ligand interactions. Biotechnol Annu Rev 10 (2004) 151-188
10. Bahou W.F., Ginsburg D., Sikkink R., Litwiller R., and Fass D.N. A Monoclonal-Antibody to von Willebrand-Factor (VWF) inhibits Factor-VIII binding-localization of Its antigenic determinant to a nonadecapeptide at the amino terminus of the mature VWF oolypeptide. J Clin Invest 84 (1989) 56-61
11. Cacheris P.M., Nichols W.C., and Ginsburg D. Molecular characterization of a unique von Willebrand disease variant - a novel mutation affecting von Willebrand-factor factor-VIII interaction. J Biol Chem 266 (1991) 13499-13502
12. Fressinaud E., Mazurier C., and Meyer D. Molecular genetics of type 2 von Willebrand disease. Int J Hematol 75 (2002) 9-18
13. van den Brink E.N., Turenhout E.A., Bank C.M., Fijnvandraat K., Peters M., and Voorberg J. Molecular analysis of human anti-factor VIII antibodies by V gene phage display identifies a new epitope in the acidic region following the A2 domain. Blood 96 (2000) 540-545
14. Kuwabara I., Maruyama H., Kamisue S., Shima M., Yoshioka A., and Maruyama I.N. Mapping of the minimal domain encoding a conformational epitope by lambda phage surface display: factor VIII inhibitor antibodies from haemophilia A patients. J Immunol Methods 224 (1999) 89-99
15. Rowley MJ, Connor K, Wijeyewickrema L. Phage display for epitope determination: A paradigm for identifying receptor-ligand interactions. Biotechnology Annual Review. Volume 10 ed. Elsevier; 2004. p. 151-88.
16. Mullaney B.P., and Pallavicini M.G. Protein-protein interactions in hematology and phage display. Exp Hematol 29 (2001) 1136-1146
17. Ginsburg D., Handin R.I., Bonthron D.T., Donlon T.A., Bruns G.A.P., Latt S.A., et al. Human von Willebrand factor (VWF) - isolation of complementary-DNA (cDNA) clones and chromosomal localization. Science 228 (1985) 1401-1406
18. Al-bukhari T.A., Tighe P., and Todd I. An immuno-precipitation assay for determining specific interactions between antibodies and phage selected from random peptide expression libraries. J Immunol Methods 264 (2002) 163-171
19. Pietu G., Ribba A.S., Cherel G., Siguret V., Obert B., Rouault C., et al. Epitope mapping of inhibitory monoclonal antibodies to human von Willebrand factor by using recombinant cDNA libraries. Thromb Haemost 71 (1994) 788-792
20. Ginsburg D., Bockenstedt P.L., Allen E.A., Fox D.A., Foster P.A., Ruggeri Z.M., et al. Fine mapping of monoclonal antibody epitopes on human von Willebrand factor using a recombinant peptide library. Thromb Haemost 67 (1992) 166-171
21. Jameson B.A., and Wolf H. The antigenic index - a novel algorithm for predicting antigenic determinants. Comput Appl Biosci 4 (1988) 181-186
22. Emini E.A., Hughes J.V., Perlow D.S., and Boger J. Induction of Hepatitis-A virus-neutralizing antibody by a virus-specific synthetic peptide. J Virol 55 (1985) 836-839
23. Kyte J., and Doolittle R.F. A simple method for displaying the hydropathic character of a protein. J Mol Biol 157 (1982) 105-132
24. Lynch D.C., Zimmerman T.S., Collins C.J., Brown M., Morin M.J., Ling E.H., et al. Molecular-cloning of cDNA for human von Willebrand-factor - authentication by a new method. Cell 41 (1985) 49-56
25. Verweij C.L., Devries C.J.M., Distel B., Vanzonneveld A.J., Vankessel A.G., Vanmourik J.A., et al. Construction of cDNA coding for human von Willebrand factor using antibody probes for colony screening and mapping of the chromosomal gene. Nucleic Acids Res 13 (1985) 4699-4717
26. Sadler J.E., Sheltoninloes B.B., Sorace J.M., Harlan J.M., Titani K., and Davie E.W. Cloning and characterization of 2 cDNAs coding for human von Willebrand factor. Proc Natl Acad Sci U S A 82 (1985) 6394-6398
27. De Luca M., Facey D.A., Favaloro E.J., Hertzberg M.S., Whisstock J.C., McNally T., et al. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation. Blood 95 (2000) 164-172